AllStripes

<p><strong>Headquarters&colon; <&sol;strong>121 2nd St&period;&comma; San Francisco&comma; CA 94105<br &sol;>&NewLine;<strong>CEO<&sol;strong>&colon; Nancy Yu<br &sol;>&NewLine;<strong>Employees&colon; <&sol;strong>50<br &sol;>&NewLine;<strong>Privately held<&sol;strong><br &sol;>&NewLine;<strong>Website<&sol;strong>&colon; <a href&equals;"https&colon;&sol;&sol;www&period;allstripes&period;com&sol;">www&period;allstripes&period;com<&sol;a><br &sol;>&NewLine;<a href&equals;"https&colon;&sol;&sol;www&period;allstripes&period;com&sol;careers"><strong>Careers<&sol;strong><&sol;a><&sol;p>&NewLine;<p>AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases&period; AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development&comma; as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data&period;<&sol;p>&NewLine;<p>AllStripes is currently partnering with more than 30 patient advocacy organizations across its 40 conditions&comma; supporting more than 3&comma;000 users to date&period; As a public benefit corporation &lpar;PBC&rpar;&comma; AllStripes is advocating for the importance of real-world evidence in development of treatments and is continuing to build tools that make research more inclusive for the global rare disease community&period;<&sol;p>&NewLine;<p>In August 2021&comma; the company raised a &dollar;50 million Series B funding round led by Lux Capital&comma; and joined by JAZZ Venture Partners&comma; Spark Capital&comma; Medidata Solutions &lpar;a Dassault Systèmes company&rpar;&comma; McKesson Ventures&comma; and Maveron&comma; along with angel investors including Arif Nathoo&comma; CEO of Komodo Health&comma; and Leila Zegna&comma; Director of the Kabuki Syndrome Foundation&period; The funding will support launching 100 new rare disease research programs&period;<&sol;p>&NewLine;<p>AllStripes &lpar;formerly RDMD&rpar; was co-founded in 2017 by CEO Nancy Yu and Onno Faber&comma; a rare disease patient deeply frustrated by the drug development process&period;<&sol;p>&NewLine;<p>The name AllStripes was inspired by the official symbol for the rare disease community&comma; the zebra&period;<&sol;p>&NewLine;<p><strong>Employee Benefits<&sol;strong><&sol;p>&NewLine;<ul>&NewLine;<li>90&percnt; covered medical&comma; dental&comma; &amp&semi; vision&semi; 75&percnt; for dependents<&sol;li>&NewLine;<li>Paid Time Off &plus; 14 paid holidays per year<&sol;li>&NewLine;<li>12 weeks parental and family leave<&sol;li>&NewLine;<li>401&lpar;k&rpar;<&sol;li>&NewLine;<li>Life and disability insurance<&sol;li>&NewLine;<li>Cell and Internet reimbursement<&sol;li>&NewLine;<li>Team lunch and activities<&sol;li>&NewLine;<li>Home work setup budget<&sol;li>&NewLine;<&sol;ul>&NewLine;<p><strong>Updated August 27&comma; 2021<&sol;strong><&sol;p>&NewLine;